Final NHS green light for Amgen’s Kyprolis

20th July 2017 Uncategorised 0

Patients living with multiple myeloma across England and Wales should now get ‘routine’ access to Amgen’s Kyprolis on the NHS within three months following a final green light from the National Institute for Health and Care Excellence.

More: Final NHS green light for Amgen’s Kyprolis
Source: News